Detalhe da pesquisa
1.
Efficacy and Safety of Tolterodine and Pilocarpine in Patients with Overactive Bladder.
J Urol
; 202(3): 564-573, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31009289
2.
Patient-optimized doses of fesoterodine improve bladder symptoms in an open-label, flexible-dose study.
BJU Int
; 107(4): 603-11, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20860648
3.
Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures.
Int Urogynecol J
; 21(12): 1479-83, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20645075
4.
Additional low-dose antimuscarinics can improve overactive bladder symptoms in patients with suboptimal response to beta 3 agonist monotherapy.
Investig Clin Urol
; 58(4): 261-266, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28681036
5.
Health Related Quality of Life in Patients with Side-Effects after Antimuscarinic Treatment for Overactive Bladder.
Low Urin Tract Symptoms
; 9(3): 171-175, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27291463
6.
A prospective, observational study to assess the association between dry mouth and solifenacin treatment in patients with overactive bladder syndrome.
Int Urol Nephrol
; 47(2): 235-42, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25503446
7.
Characterization of iridium film as a stimulating neural electrode.
Biomaterials
; 23(11): 2375-80, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12013185
8.
Efficacy, Safety and Tolerability of Fesoterodine in Asian Patients with Overactive Bladder.
Low Urin Tract Symptoms
; 3(1): 43-50, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26676351
9.
Tolterodine: as effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder.
Int J Urol
; 9(5): 247-52, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12060436
10.
Endoscopic treatment of vesicoureteral reflux with polydimethylsiloxane in adult women.
Eur Urol
; 45(6): 787-9, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15149753